Press release
Cancer Biomarker Market Revenue Trends and Growth Potential 2026 to 2035
Cancer Biomarker Market
According to the latest research by InsightAce Analytic, the Global Cancer Biomarker Market is valued at USD 28.5 Bn in 2024, and it is expected to reach USD 44.5 Bn by 2034, with a CAGR of 4.7% during the forecast period of 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2563
Cancer biomarkers encompass a wide range of biological indicators, including genetic, proteomic, and metabolic markers, that provide critical information about cancer initiation, progression, and molecular behavior. These biomarkers are central to advancing the understanding of tumor biology and play a vital role in early diagnosis, prognosis assessment, and the development of targeted therapeutic strategies. Their integration into precision oncology is reshaping clinical practice by enabling more individualized and effective treatment approaches.
The global cancer biomarkers market is demonstrating strong growth, driven by ongoing innovation in diagnostic technologies and the rising worldwide prevalence of cancer. Increased focus on early detection, disease monitoring, and personalized healthcare is further supporting market expansion. Additional drivers include higher investments in research and development, broader adoption of precision medicine frameworks, and growing demand for minimally invasive diagnostic solutions.
Moreover, the expanding use of companion diagnostics alongside targeted therapies is improving treatment precision and patient outcomes, thereby reinforcing market development. At the same time, the industry faces challenges such as the high cost of biomarker discovery and validation, complex regulatory approval processes, and the biological heterogeneity of cancer. Despite these constraints, continuous technological progress, strategic collaborations between biotechnology and pharmaceutical companies, and advances in molecular diagnostics are expected to support sustained long-term growth and market evolution.
List of Prominent Players in the Cancer Biomarker Market:
• Agilent
• ARUP Laboratories
• BioReference
• Foundation Medicine
• OncoDNA
• Q2 Solutions
• Thermo Fisher Scientific
• YuceBio
• Asper Biogene
• Caris Life Sciences
• CeGaT
• Genekor Medical
• Guardant Health
• Labcorp
• MedGenome
• NeoGenomics Laboratories
• Nonacus
• Oxford Gene Technology
• Personal Genome Diagnostics
• PhenoPath
• Positive Biosciences
• Quest Diagnostics
• Tempus
Add our site to Google Preferred Sources for quality content : https://google.com/preferences/source?q=insightaceanalytic.com
Market Dynamics
Drivers:
The global cancer biomarkers market is demonstrating strong growth momentum, driven largely by expanding research and development efforts focused on identifying markers associated with treatment resistance and predicting therapeutic response. Progress in genomic and molecular profiling technologies is enabling more accurate evaluation of patient outcomes, including post-therapy prognoses, thereby strengthening clinical decision-making.
The rising global burden of cancer, together with intensified scientific investigation, continues to support market expansion. In parallel, sustained product innovation and the development of advanced biomarker pipelines by leading industry participants are accelerating market advancement. The growing emphasis on precision oncology has further increased the adoption of biomarker-based diagnostics, as healthcare systems increasingly integrate personalized medicine to improve diagnostic precision and treatment effectiveness.
Challenges:
Despite strong demand for early detection and precision-based diagnostics, the absence of consistent reimbursement frameworks in several developed markets remains a major barrier to growth. In addition, the high costs of biomarker assays, diagnostic imaging, and targeted therapies-particularly in emerging economies-limit affordability and access, constraining broader market penetration. These financial and regulatory constraints continue to hinder the full realization of the market's potential.
Regional Trends:
North America is expected to retain its leadership position in the global cancer biomarkers market, supported by a high incidence of chronic diseases, advanced technological capabilities, and a well-developed healthcare infrastructure. Robust investment in clinical and translational research further underpins the region's dominance.
Meanwhile, the Asia-Pacific region is projected to experience accelerated growth over the forecast period, driven by increasing healthcare spending, government initiatives to support oncology research, and strategic expansion by global market participants. The growing footprint of major biotechnology and diagnostics companies in the region is expected to generate substantial opportunities, positioning Asia-Pacific as a key growth engine in the global cancer biomarkers market.
Recent Developments
• In November 2023, Agilent received FDA approval for PD-L1 IHC 22C3 pharmDx in gastric or gastroesophageal junction (GEJ) adenocarcinoma.
• In December 2022, QIAGEN received FDA approval for a companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer.
• In November 2022, Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) instrumentation and reagents, acquired Empire Genomics, a market leader in molecular biomarkers to aid in cancer research and diagnostics.
• In May 2022, Illumina introduced a new pan-cancer companion diagnostic to match patients with rare genetic mutations to targeted therapy.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2563
Segmentation of Cancer Biomarker Market-
Cancer Biomarker Market- By Type of Biomarkers
• HER2
• MET
• EGFR
• PD-L1
• NTRK
• ALK
• Novel Biomarkers
• Other Biomarkers
Cancer Biomarker Market- By Type of Cancer
• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Thyroid Cancer
• Bladder Cancer
• Melanoma
• Non-Hodgkins Lymphoma
• Endometrial Cancer
• Kidney Cancer
• Leukemia
• Others
Cancer Biomarker Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/cancer-biomarker-market/2563
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarker Market Revenue Trends and Growth Potential 2026 to 2035 here
News-ID: 4376576 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Autonomous Driving Software Market Global Opportunity Analysis and Forecast 2026 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Autonomous Driving Software Market"-, By Level of Autonomy (L2+, L3, L4), Vehicle Type (Passenger Cars, Commercial Vehicles), Propulsion (ICE, Electric), Software Type (Perception & Planning, Chauffeur, Interior Sensing, Monitoring), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2034."
Autonomous Driving Software Market Size is valued at USD 1.84 Bn in 2024 and…
Automotive Brake Fluid Market Comprehensive Size and Share Assessment 2026 to 20 …
Automotive Brake Fluid Market Size is valued at USD 1.40 billion in 2025 and is predicted to reach USD 2.25 billion by the year 2035 at a 5.0% CAGR during the forecast period for 2026 to 2035.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1931
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global automotive brake fluid market are:
• Developments in urbanization and population
• Growing interest in automobiles …
Artificial Intelligence AI in Chemical Market Industry Insights and Future Proje …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Artificial Intelligence (AI) In Chemical Market Size, Share & Trends Analysis Report By Type (Hardware, Software, Services), By Application (Discovery of new materials, Production optimization, Pricing optimization, Load forecasting of raw materials, Product portfolio optimization, Feedstock optimization, Process management & control), By End User (Base Chemicals & Petrochemicals, Specialty Chemicals, Agrochemicals), Region, Market Outlook And…
Algae-Based Ingredients Market Growth Outlook and Strategic Analysis 2026 to 203 …
Algae-Based Ingredients Market Size is valued at USD 4.24 Billion in 2024 and is predicted to reach USD 8.64 Billion by the year 2034 at a 7.5% CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1461
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Algae-Based Ingredients Market are:
• Increasing consumer demand for plant-based products
• Rising awareness of the nutritional benefits of algae
• Expanding…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
